Corient Private Wealth LLC Lowers Stock Position in Cigna Group $CI

Corient Private Wealth LLC decreased its holdings in shares of Cigna Group (NYSE:CI) by 25.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 140,603 shares of the health services provider’s stock after selling 47,461 shares during the period. Corient Private Wealth LLC’s holdings in Cigna Group were worth $38,705,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of CI. Wilkerson Advisory Group LLC purchased a new position in Cigna Group in the fourth quarter worth $25,000. Beacon Financial Strategies CORP acquired a new stake in Cigna Group in the fourth quarter valued at $28,000. Kemnay Advisory Services Inc. purchased a new stake in shares of Cigna Group during the 4th quarter worth $29,000. Prosperity Bancshares Inc acquired a new position in shares of Cigna Group during the 4th quarter worth $29,000. Finally, Lodestone Wealth Management LLC acquired a new position in shares of Cigna Group during the 4th quarter worth $32,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Cigna Group

In related news, CAO Jamie G. Kates sold 899 shares of the company’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This represents a 27.52% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO David Cordani sold 201,878 shares of the stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the sale, the chief executive officer owned 34,337 shares in the company, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.60% of the company’s stock.

Wall Street Analysts Forecast Growth

CI has been the subject of several recent analyst reports. Piper Sandler reduced their price objective on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a research note on Wednesday, June 3rd. Wells Fargo & Company upped their target price on shares of Cigna Group from $300.00 to $305.00 and gave the stock an “equal weight” rating in a research report on Friday, May 1st. Raymond James Financial set a $340.00 target price on shares of Cigna Group in a report on Friday, May 1st. Guggenheim boosted their price target on Cigna Group from $334.00 to $338.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. Finally, Sanford C. Bernstein upped their price target on Cigna Group from $358.00 to $371.00 and gave the stock an “outperform” rating in a report on Tuesday, May 5th. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $338.30.

Cigna Group Price Performance

Cigna Group stock opened at $279.63 on Monday. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. The firm’s 50-day simple moving average is $283.79 and its 200 day simple moving average is $278.36. Cigna Group has a 52 week low of $239.51 and a 52 week high of $338.89. The firm has a market capitalization of $73.97 billion, a PE ratio of 11.85, a P/E/G ratio of 1.08 and a beta of 0.28.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The company had revenue of $68.52 billion during the quarter, compared to analysts’ expectations of $66.29 billion. During the same quarter in the previous year, the business posted $6.74 earnings per share. The firm’s quarterly revenue was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, equities research analysts predict that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Thursday, June 4th were given a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date was Thursday, June 4th. Cigna Group’s payout ratio is currently 26.45%.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.